Funding Amount

Up to $500,000 for translational/correlative grants; Up to $800,000 for clinical trials

Deadline

Expected ~November

Based on past cycles

Grant Type

Foundation

Deadline history & next window

Cycle
Annual
Current deadline
November 15, 2026
Tracked since
April 2026

Deadlines typically fall in: November

From the program guidelines: “LOI deadline: Mid-November each year”

Can we apply?

Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.

Other requirements

  • Researchers with osteosarcoma research proposals
  • Studies focused on developing better treatments and ultimately a cure for osteosarcoma
  • Both preclinical and clinical research welcome

Overview

Annual Grants Program

Geographic Scope: National and international

Focus Areas:

  • Clinical trials of new potential therapies
  • Correlative science (evaluation of how and why potential new therapies work or don't work in clinical trials)
  • Basic biology of osteosarcoma cancer and its metastasis
  • Translational research (pre-clinical research bridging laboratory findings to clinical application)
  • High-risk/high-impact research (bold, pioneering ideas that challenge traditional approaches)

Award Amounts:

  • Translational/correlative grants: Up to $500,000
  • Clinical trials: Up to $800,000
  • High-risk/high-impact studies: Variable (e.g., $100,000)

Eligibility:

  • Researchers with osteosarcoma research proposals
  • Studies focused on developing better treatments and ultimately a cure for osteosarcoma
  • Both preclinical and clinical research welcome

Application Process:

  • Two-stage annual grant cycle
  • Letters of Intent (LOI) due mid-November each year
  • Full applications follow LOI acceptance
  • Expert review committee evaluates submissions
  • Awards announced in spring

What They Fund:

  • Research using new technologies
  • Projects with clear timeline to clinical testing
  • Immunotherapy approaches
  • CAR-T cell therapy developments
  • Studies on osteosarcoma metastasis prevention
  • Genomics and molecular biology research

What They Don't Fund:

  • Not explicitly stated

Background:

  • OSI launched in 2017 and has awarded over $5 million to osteosarcoma research since inception
  • Standard treatments for osteosarcoma have not changed in 40 years
  • OSI is a leading funder of osteosarcoma research
  • Strategic Advisory Board includes Nobel Prize recipient and experts across multiple disciplines
  • Starting in 2019, OSI awards grants in three main categories; added high-risk/high-impact category in 2023

Contact Information:

  • Address: 3963 Maple Avenue Suite 390, Dallas, TX 75219
  • Phone: 972.903.8408
  • Email: info@osinst.org
  • Website: osinst.org

How to Apply

Application Process

Two-Stage Annual Grant Cycle:

  1. Stage One: Letter of Intent (LOI)
    • LOI deadline: Mid-November each year
    • LOI submissions outline the proposed research
  2. Stage Two: Full Application
    • Invited after LOI acceptance
    • Full applications required for selected LOI submissions

Expert Review:

  • Submissions evaluated by OSI's expert review committee
  • Committee provides feedback to applicants, even those not selected
  • Feedback includes specific advice and direction for improvement

Award Announcements:

  • Grants announced in spring (typically June)

Post-Award Requirements:

  • Principal Investigators must provide progress reports every six months
  • Reports shared with OSI Strategic Advisory Board
  • Results made available to the public upon completion
  • Emphasis on transparency and accountability

Additional Support:

  • OSI offers invaluable feedback, advice, and guidance to researchers
  • $20,000 spot/ad hoc grants available to help researchers elevate work for future resubmission
  • Researchers receive mentorship from Nobel Prize recipient and expert board members

What The Osteosarcoma Institute actually gave

Source: IRS Form 990, 2024

Grants in 2024
8
Total given
$1.19M
Median grant
$125K
Range
$101K–$307K
  • By dollars: Massachusetts 26%, California 24%, Georgia 10%. Top recipient cities: Boston, MA; San Francisco, CA; Atlanta, GA.
  • 0% of grants with a stated purpose were for general or operating support.

Example grants

  • Dana Farber Cancer Institute · Boston, MA

    Clinical trial and correlative research grants

    $307K

  • University of CA San Francisco · San Francisco, CA

    Translational research grants

    $175K

  • Regents of Emory University · Atlanta, GA

    Translational research grants

    $125K

  • Regents of Northwestern University · Evanson, IL

    Translational research grants

    $125K

  • Baylor College of Medicine · Houston, TX

    Translational research grants

    $125K

IRS Form 990, 2024. Amounts as reported by the funder. Full 990 history →

Focus Areas & Funding Uses

Fields of Work

  • Science research
  • Cancer

Categories

Browse similar grants by category

Related Grants

Open grants from this funder and similar programs

Your AI grants department

Ready to apply for Annual Grants?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found Annual Grants. Now let's win it.

Start writing